Short Interest in Henry Schein, Inc. (HSIC) Decreases By 7.3%

Henry Schein, Inc. (NASDAQ:HSIC) was the recipient of a significant drop in short interest in the month of September. As of September 14th, there was short interest totalling 16,020,723 shares, a drop of 7.3% from the August 31st total of 17,291,234 shares. Based on an average trading volume of 1,103,270 shares, the short-interest ratio is currently 14.5 days. Approximately 10.6% of the shares of the company are short sold.

NASDAQ:HSIC opened at $85.21 on Friday. The firm has a market cap of $12.91 billion, a P/E ratio of 23.68, a price-to-earnings-growth ratio of 2.43 and a beta of 0.98. Henry Schein has a 52-week low of $62.56 and a 52-week high of $87.41. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.29 and a quick ratio of 0.68.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Monday, August 6th. The company reported $1.04 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.01 by $0.03. The company had revenue of $3.33 billion during the quarter, compared to analyst estimates of $3.31 billion. Henry Schein had a return on equity of 20.40% and a net margin of 3.15%. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the company earned $0.88 earnings per share. equities research analysts anticipate that Henry Schein will post 4.12 EPS for the current year.

A number of equities analysts have recently commented on the company. BidaskClub lowered Henry Schein from a “buy” rating to a “hold” rating in a report on Thursday, August 30th. Barrington Research reaffirmed a “buy” rating and issued a $92.00 price target on shares of Henry Schein in a report on Tuesday, August 7th. ValuEngine raised Henry Schein from a “strong sell” rating to a “sell” rating in a report on Thursday, September 13th. Stifel Nicolaus raised their price target on Henry Schein from $76.00 to $81.00 and gave the stock a “hold” rating in a report on Tuesday, August 7th. Finally, Zacks Investment Research raised Henry Schein from a “hold” rating to a “buy” rating and set a $86.00 price target for the company in a report on Wednesday, July 25th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and nine have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $84.11.

A number of large investors have recently bought and sold shares of HSIC. FMR LLC lifted its stake in Henry Schein by 167.3% during the second quarter. FMR LLC now owns 6,632,783 shares of the company’s stock worth $481,805,000 after purchasing an additional 4,151,179 shares during the last quarter. Select Equity Group L.P. lifted its stake in Henry Schein by 68.2% during the first quarter. Select Equity Group L.P. now owns 6,476,540 shares of the company’s stock worth $435,288,000 after purchasing an additional 2,625,408 shares during the last quarter. Point72 Asset Management L.P. lifted its stake in Henry Schein by 2,573.5% during the second quarter. Point72 Asset Management L.P. now owns 802,047 shares of the company’s stock worth $58,261,000 after purchasing an additional 772,047 shares during the last quarter. American Century Companies Inc. lifted its stake in Henry Schein by 21.2% during the second quarter. American Century Companies Inc. now owns 2,191,660 shares of the company’s stock worth $159,202,000 after purchasing an additional 383,479 shares during the last quarter. Finally, Glenmede Trust Co. NA lifted its stake in Henry Schein by 11,084.6% during the second quarter. Glenmede Trust Co. NA now owns 355,000 shares of the company’s stock worth $25,787,000 after purchasing an additional 351,826 shares during the last quarter. 96.65% of the stock is owned by institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More: Asset Allocation and Your Retirement

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply